#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 4

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 955
countries: 28
conditions: 2 101

3 955 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Myelodysplastic syndrome

Not recruiting

Registered drug

Study of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Follicular lymphoma+2

Not recruiting

Registered drugNo placebo

Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drugNo placebo

Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Epoetin Alfa

Contact Research Centre

Myelofibrosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Aprepitant

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study of Zilovertamab Vedotin with Drug Combination for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Gemcitabine

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid

Contact Research Centre

Polycythaemia vera

Not recruiting

Investigational

Study of SLN124 for Patients with Polycythemia Vera

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Tmprss6 Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drugNo placebo

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Epoetin Alfa

Contact Research Centre

Macular oedema+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Diabetic retinopathy

Not recruiting

Investigational

Study on BI 764524 for Patients with Moderate to Severe Diabetic Retinopathy

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Bi 764524

Contact Research Centre

Cardiac failure+4

Not recruiting

Registered drug

Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Cdr132L

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.